Načítá se...
Chemotherapy in frail elderly patients with hormone-refractory prostate cancer: A “real world” experience
BACKGROUND: In elderly patients affected by metastatic castration-resistant prostate cancer (mCRPC) chemotherapic treatment may be the choice if one considers not only the chronological age, but also the clinical status, the functional reserve, and the vulnerability of patients. Several studies have...
Uloženo v:
| Vydáno v: | Prostate Int |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Asian Pacific Prostate Society
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4789324/ https://ncbi.nlm.nih.gov/pubmed/27014659 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.prnil.2015.12.003 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|